Lung Cancer ECOG 3508

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase II Randomized Trial of Paclitaxel, Carboplatin, Bevacizumab with or without IMC-A12 in Patients with Advanced Non-Squamous, Non-Small Cell Lung Cancer.